Quang-De Nguyen

7PUBLICATIONS
150CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 21, 2025
18F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors.

Anand Giddabasappa, Ziyue Karen Jiang, Bing Yang

|Feb 11, 2025
Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial Carcinoma.

Zelei Yang, Saie Mogre, Hyeji Jun

|Jul 12, 2024
CAR memory-like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer.

Mubin Tarannum, Khanhlinh Dinh, Juliana Vergara

|Jun 04, 2024
Obesogenic High-Fat Diet and MYC Cooperate to Promote Lactate Accumulation and Tumor Microenvironment Remodeling in Prostate Cancer.

Nadia Boufaied, Paolo Chetta, Tarek Hallal

|Feb 21, 2024
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.

Cristina Guarducci, Agostina Nardone, Douglas Russo

|Nov 05, 2021
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance.

Yihao Li, Xintao Qiu, Xiaoqing Wang

Pageof 2

Frequent Collaborators

2 joint publications

Amy Cameron

2 joint publications

Ying Huang

1 joint publications

Mariella G Filbin

1 joint publications

Itay Tirosh